| Budget Amount *help |
¥46,930,000 (Direct Cost: ¥36,100,000、Indirect Cost: ¥10,830,000)
Fiscal Year 2014: ¥11,440,000 (Direct Cost: ¥8,800,000、Indirect Cost: ¥2,640,000)
Fiscal Year 2013: ¥9,490,000 (Direct Cost: ¥7,300,000、Indirect Cost: ¥2,190,000)
Fiscal Year 2012: ¥8,580,000 (Direct Cost: ¥6,600,000、Indirect Cost: ¥1,980,000)
Fiscal Year 2011: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
Fiscal Year 2010: ¥9,490,000 (Direct Cost: ¥7,300,000、Indirect Cost: ¥2,190,000)
|
|---|
| Outline of Final Research Achievements |
Toward engineering implantable pancreatic beta cell or liver cell tissues, an integrative methodologies that fully utilizes the advantages of both tissue element assembly in a micro-cale and large 3D scaffold having a flow channel network in a macro-scale. Model scaffolds was fabricated by the 3D selective laser sintering (SLS) process. Good results of the perfusion culture of liver cell aggregates proved the high feasibility of the methodology. In addition, we succeeded in the preparation of hemoglobin-based artificial oxygen carrier showing lower cytotoxicity.
|
